Influenza Vaccination of Nursing Home Workers.
NCT00359554 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4000
Last updated 2007-02-07
Summary
The objective of this study is to demonstrate that influenza vaccination of nursing home workers is an effective intervention for reducing mortality of elderly people.
Conditions
- Influenza Disease
Interventions
- BIOLOGICAL
-
VAXIGRIPPE
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Fabrice CARRAT, MD, · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Completion
- 2007-10-31
Countries
- France
Study Locations
More Related Trials
-
Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
NCT02247362 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects
NCT01357265 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
NCT06286488 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population
NCT02236052 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais
NCT05895955 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
NCT02015494 ·Status: UNKNOWN ·Phase: PHASE1
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit
NCT02758145 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg
NCT05569239 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
High-Dose Influenza Vaccine in Nursing Homes
NCT01815268 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults
NCT01172054 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00329966 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
NCT00966238 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers
NCT01481467 ·Status: UNKNOWN ·Phase: NA
-
A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine
NCT00505453 ·Status: COMPLETED ·Phase: PHASE3
-
High Dose Influenza Vaccine in Nursing Home - Pilot Study
NCT01720277 ·Status: COMPLETED ·Phase: PHASE4
-
Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)
NCT01424371 ·Status: UNKNOWN
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults
NCT02831751 ·Status: COMPLETED ·Phase: PHASE2
-
Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX
NCT03232567 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™
NCT00306982 ·Status: COMPLETED
-
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
NCT02233816 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
NCT01289535 ·Status: UNKNOWN ·Phase: PHASE4